Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies

BACKGROUND/AIM: To assess the treatment effect of 0.1% ciclosporin A cationic emulsion (CsA CE) versus vehicle on signs/symptoms of dry eye disease (DED) in various subgroups (moderate-to-severe DED/severe DED/Sjögren’s syndrome (SS)/SS with severe DED). METHODS: Pooled data were analysed from two s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Ophthalmol
Asıl Yazarlar: Leonardi, Andrea, Messmer, Elisabeth M, Labetoulle, Marc, Amrane, Mourad, Garrigue, Jean-Sébastien, Ismail, Dahlia, Sainz-de-la-Maza, Maite, Figueiredo, Francisco C, Baudouin, Christophe
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2019
Konular:
Clinical Science
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6317444/
https://ncbi.nlm.nih.gov/pubmed/29545413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2017-311801
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller